KCNN2 and glioblastoma: Combined treatment with the AQP1 water channel inhibitor AqB013 led to a further 20 to 40% reduction of invasion over Apamin alone (43), indicating key roles for ion channels such as SK2 in GBM tumor mechanisms, and supporting Apamin as a promising drug candidate in GBM therapy.